Sign in
4

Changes in Ownership

PALVELLA THERAPEUTICS, INC. Filed Acc 0001562180-19-004585

Options or other derivatives

  • SVP, Chief Scientific Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kaufmann Hitto · SVP, Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-08-30 Grant or award : show line 1 in the form Stock Option (right to buy) +300,000 300,000 D
Loading xslF345X03/primarydocument.xml…